See the DrugPatentWatch profile for Trelegy
Trelegy Ellipta, a medication used to treat COPD, can be expensive without insurance coverage. The cost can vary significantly depending on the pharmacy and the specific dosage prescribed.
How much does Trelegy Ellipta cost without insurance?
Without insurance, a single inhaler of Trelegy Ellipta can cost anywhere from $300 to over $500. This price can fluctuate based on the pharmacy where it is purchased.
Are there any ways to get Trelegy Ellipta for less?
Patients looking for more affordable options may find assistance programs offered by the manufacturer, GSK. These programs can sometimes provide discounts or free medication for eligible individuals. Checking the GSK website or inquiring with a healthcare provider can offer more information on these programs. Additionally, comparing prices at different pharmacies might reveal cost savings.
What is Trelegy Ellipta used for?
Trelegy Ellipta is a combination inhaler containing fluticasone furoate, umeclidinium, and vilanterol. It is prescribed to manage COPD, which includes chronic bronchitis and emphysema. It works by reducing inflammation in the airways and relaxing the muscles around them to make breathing easier.
When does the patent for Trelegy Ellipta expire?
Information regarding specific patent expiry dates for Trelegy Ellipta can be found on specialized drug patent tracking websites. These sites often provide detailed timelines for patent protection and potential generic entry [1].
What are the alternatives to Trelegy Ellipta?
Several alternative COPD treatments exist, including other combination inhalers, single-agent inhalers, and oral medications. The best alternative depends on an individual's specific condition and response to treatment. A healthcare provider can discuss these options, which may include medications like Symbicort, Advair, Spiriva, or Tudorza, among others.
*
**Sources
1. DrugPatentWatch.com